India HIV Drugs Industry Size, Growth, Outlook and Report 2024-2032

According to the latest report by IMARC Group, the India HIV drugs market size reached USD 1,036 Million in 2023. Looking forward, IMARC Group expects the market to reach USD 1,519 Million by 2032, exhibiting a growth rate (CAGR) of 4.30% during 2024-2032. The market is growing due to increased awareness, government initiatives, and advancements in antiretroviral therapies, improving accessibility and treatment outcomes for HIV patients across the country.

Explore the Full Report: [URL]https://www.imarcgroup.com/ind....ia-hiv-drugs-market/

India HIV Drugs Market Trends and Drivers:

The growing consciousness of HIV prevention and treatment, as well as efforts by government authorities to improve access to antiretroviral therapy (ART) are the factors responsible for the growth of the India HIV drugs market. Additionally, the government authorities have made significant strides in providing free ART to those living with HIV with the introduction of national programs like the National AIDS Control Programme (NACP).